GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DVx Inc (TSE:3079) » Definitions » Total Liabilities

DVx (TSE:3079) Total Liabilities : 円13,629 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is DVx Total Liabilities?

DVx's Total Liabilities for the quarter that ended in Dec. 2023 was 円13,629 Mil.

DVx's quarterly Total Liabilities declined from Jun. 2023 (円13,614.88 Mil) to Sep. 2023 (円13,582.71 Mil) but then increased from Sep. 2023 (円13,582.71 Mil) to Dec. 2023 (円13,628.62 Mil).

DVx's annual Total Liabilities increased from Mar. 2021 (円12,646.32 Mil) to Mar. 2022 (円13,623.02 Mil) and increased from Mar. 2022 (円13,623.02 Mil) to Mar. 2023 (円14,278.06 Mil).


DVx Total Liabilities Historical Data

The historical data trend for DVx's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DVx Total Liabilities Chart

DVx Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,176.48 12,800.64 12,646.32 13,623.02 14,278.06

DVx Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,329.47 14,278.06 13,614.88 13,582.71 13,628.62

DVx Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

DVx's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13770.586+(8.773+41.866000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+456.831)
=14,278

Total Liabilities=Total Assets (A: Mar. 2023 )-Total Equity (A: Mar. 2023 )
=23589.982-9311.926
=14,278

DVx's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=13104.966+(0+45.357999999999
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+478.298)
=13,629

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=22768.499-9139.877
=13,629

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DVx Total Liabilities Related Terms

Thank you for viewing the detailed overview of DVx's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


DVx (TSE:3079) Business Description

Traded in Other Exchanges
N/A
Address
Mejiro Nakano Building, 5th Floor, 2-17-22 Takada, Toshima-ku, Tokyo, JPN, 171-0033
DVx Inc is engaged in manufacture, sale, repair, and leasing of medical equipment and related peripheral equipment, research and development of medical equipment, provide in house and out of service consulting services and services for medical and medical devices, and providing medical publication and market research.

DVx (TSE:3079) Headlines

No Headlines